X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (120) 120
index medicus (99) 99
humans (95) 95
female (90) 90
breast cancer (79) 79
middle aged (73) 73
adult (62) 62
breast neoplasms - drug therapy (61) 61
chemotherapy (61) 61
aged (57) 57
breast neoplasms - pathology (55) 55
cancer (53) 53
antineoplastic combined chemotherapy protocols - therapeutic use (52) 52
treatment outcome (43) 43
obstetrics & gynecology (41) 41
neoadjuvant therapy (37) 37
survival (36) 36
trastuzumab (34) 34
therapy (33) 33
prognosis (30) 30
care and treatment (29) 29
chemotherapy, adjuvant (27) 27
neoplasm staging (27) 27
taxoids - administration & dosage (27) 27
medicine & public health (26) 26
adjuvant treatment (24) 24
clinical trials (24) 24
pathological complete response (24) 24
antineoplastic combined chemotherapy protocols - adverse effects (23) 23
breast neoplasms - mortality (22) 22
cyclophosphamide (21) 21
disease-free survival (21) 21
prospective studies (21) 21
cyclophosphamide - administration & dosage (20) 20
doxorubicin (20) 20
capecitabine (19) 19
neoadjuvant chemotherapy (19) 19
research (19) 19
tumors (19) 19
breast neoplasms - surgery (18) 18
multicenter (18) 18
paclitaxel (18) 18
docetaxel (17) 17
health aspects (17) 17
open-label (17) 17
analysis (16) 16
epirubicin - administration & dosage (16) 16
lapatinib (16) 16
adjuvant chemotherapy (15) 15
breast neoplasms - metabolism (15) 15
further section · weitere sektionen (15) 15
kaplan-meier estimate (15) 15
patients (15) 15
women (15) 15
young adult (15) 15
aged, 80 and over (14) 14
erbb-2 protein (14) 14
further section (14) 14
germany (14) 14
metastasis (14) 14
paclitaxel - administration & dosage (14) 14
surgery (14) 14
cancer patients (13) 13
her2 (13) 13
preoperative chemotherapy (13) 13
anthracyclines (12) 12
deoxycytidine - administration & dosage (12) 12
deoxycytidine - analogs & derivatives (12) 12
drug administration schedule (12) 12
medical prognosis (12) 12
skin and connective tissue diseases (12) 12
bevacizumab (11) 11
biomarkers, tumor - analysis (11) 11
breast neoplasms - genetics (11) 11
drug therapy (11) 11
expression (11) 11
fluorouracil - administration & dosage (11) 11
gebfra science (11) 11
gene expression (11) 11
neoplasm grading (11) 11
oncology, experimental (11) 11
proportional hazards models (11) 11
randomized controlled trials as topic (11) 11
time factors (11) 11
breast neoplasms - chemistry (10) 10
cancer therapies (10) 10
early breast cancer (10) 10
follow-up (10) 10
follow-up studies (10) 10
hematology, oncology and palliative medicine (10) 10
immunohistochemistry (10) 10
receptor, erbb-2 - metabolism (10) 10
trial (10) 10
antibodies, monoclonal, humanized (9) 9
antineoplastic agents - therapeutic use (9) 9
antineoplastic combined chemotherapy protocols - administration & dosage (9) 9
combination (9) 9
doxorubicin - administration & dosage (9) 9
epidermal growth factor (9) 9
fluorouracil - analogs & derivatives (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England journal of medicine, ISSN 1533-4406, 2012, Volume 366, Issue 4, pp. 299 - 309
Journal Article
The lancet oncology, ISSN 1470-2045, 2012, Volume 13, Issue 2, pp. 135 - 144
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2012, Volume 30, Issue 15, pp. 1796 - 1804
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2010, Volume 28, Issue 12, pp. 2024 - 2031
Journal Article
Breast cancer research and treatment, ISSN 1573-7217, 2010, Volume 124, Issue 1, pp. 133 - 140
Journal Article
JNCI : Journal of the National Cancer Institute, ISSN 1460-2105, 2008, Volume 100, Issue 8, pp. 542 - 551
... GeparTrio Trial Gunter von Minckwitz , Sherko Kmmel , Petra Vogel , Claus Hanusch , Holger Eidtmann , Jrn Hilfrich , Bernd Gerber , Jens Huober , Serban Dan Costa... 
THERAPY | GEPARDUO | ONCOLOGY | CHEMOTHERAPY | Breast Neoplasms - surgery | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Capecitabine | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents, Alkylating - administration & dosage | Vinblastine - administration & dosage | Antimetabolites, Antineoplastic - administration & dosage | Antineoplastic Agents, Phytogenic - administration & dosage | Breast Neoplasms - chemistry | Carcinoma, Ductal, Breast - drug therapy | Fluorouracil - administration & dosage | Vinblastine - analogs & derivatives | Mastectomy, Segmental | Adult | Female | Breast Neoplasms - diagnostic imaging | Chemotherapy, Adjuvant | Doxorubicin - administration & dosage | Drug Administration Schedule | Fluorouracil - analogs & derivatives | Biomarkers, Tumor - analysis | Deoxycytidine - administration & dosage | Ultrasonography, Mammary | Treatment Outcome | Breast Neoplasms - drug therapy | Antibiotics, Antineoplastic - administration & dosage | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Neoadjuvant Therapy - methods | Aged | Carcinoma, Lobular - drug therapy | Patient Compliance | Neoplasm Staging | Deoxycytidine - analogs & derivatives | Germany | Chemotherapy | Breast cancer | Drug therapy | Comparative analysis | Health aspects | Cancer | Side effects | Toxicity | Clinical outcomes | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2011, Volume 29, Issue 16, pp. 2150 - 2157
Journal Article
JNCI : Journal of the National Cancer Institute, ISSN 1460-2105, 2008, Volume 100, Issue 8, pp. 552 - 562
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2010, Volume 28, Issue 12, pp. 2015 - 2023
Journal Article
Breast cancer research and treatment, ISSN 1573-7217, 2010, Volume 125, Issue 1, pp. 145 - 156
Journal Article